Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Wegovy (semaglutide 2.4 mg) is a glucagon-like peptide-1 receptor agonist licensed for chronic weight management in adults with obesity or overweight with weight-related comorbidities
Quick Answer: Tirzepatide reduces systolic blood pressure by 5 to 10 mmHg and diastolic blood pressure by 2 to 5 mmHg in clinical trials, though it is not FDA-approved for hypertension treatment
These effects are moderately varied across studies with mixed quality levels and precision, demonstrating that these effects have a low level of certainty
Patients who experience persistent gastrointestinal symptoms may not maintain adequate fluid and electrolyte intake, increasing the risk of these complications
US$ 23.52
US$ 22.75
US$ 24.88
US$ 28.04
